March 07, 2023
Ira C. Spector, PhD, MBA, CEO and Co-Founder, SFA Therapeutics discusses how his career journey has epitomized the ability to solve problems, which is essentially the role of drug development. It has also led to the formation and strategic approach to his company’s early-stage clinical trials for using the microbiome to address chronic inflammatory diseases.
February 21, 2023
Beth MacEntee Pileggi, Head of Global Case and Safety Data Management with Janssen Pharmaceuticals of Johnson & Johnson, and Co-Lead of TransCelerate’s Pharmacovigilance Agreements Optimization Initiative, discusses the importance of safety, collaboration, TransCelerate’s positive role in the pharma industry and her passion for PV.
February 10, 2023
Melissa Easy, VP and GM, clinical technologies at IQVIA speaks about concerns with clinical technology at the SCOPE 2023 conference in Orlando, FL.
February 10, 2023
Melissa Easy, VP and GM, clinical technologies at IQVIA speaks about what should be top of mind for clinops professionals in 2023 at the SCOPE 2023 conference in Orlando, FL.
February 10, 2023
Sunny Kumar, MD, partner at GSR Ventures speaks about reducing hospital readmissions for high-risk patients at the SCOPE 2023 conference in Orlando, FL.
February 10, 2023
Sunny Kumar, MD, partner at GSR Ventures speaks about venture capital in clinical research at the SCOPE 2023 conference in Orlando, FL.